Medtronic's shareholders overwhelmingly approved its proposed, $43 billion merger with Covidien this week, including a controversial provision to cover a portion of its executives tax bills.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xQ3xmG
Cap comentari:
Publica un comentari a l'entrada